CoChat

Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy

The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Preferences, or utilities, for health outcomes are central in prostate cancer decision-making. Utilities can be elicited directly from patients using standard techniques, or indirectly, using questionnaires that incorporate preference weights from community members. OBJECTIVES: To evaluate directly elicited and indirectly elicited (questionnaire-derived, community-weighted) utilities for prostate cancer outcomes and the effects of sexual, urinary, and bowel dysfunction on them. MATERIALS AND METHODS: Utilities for the current health of 141 prostate cancer patients, recruited from ambulatory clinics, were elicited directly with the Patient Oriented Prostate Utility Scale, rating scale (PORPUS-U(RS)) and standard gamble (PORPUS-U(SG)) subscales. Patients completed the Health Utilities Index (HUI) and Quality of Well Being Scale (QWB), utility instruments incorporating community preferences, and the UCLA Prostate Cancer Index. RESULTS: Patients' treatments included radical prostatectomy (18%), radiation (60%), and hormonal (42%). Mean utility scores for current health were 0.65 (QWB), 0.79 (PORPUS-U(RS)), 0.80 (HUI), 0.86 (PORPUS-U(SG)). Utility decrements for dysfunction were small (0.08-0.14 [sexual], 0.06 to 0.13 [urinary], and 0.01 to 0.13 [bowel]), and even smaller when adjusted for concomitant changes in other quality of life (QOL) domains. CONCLUSIONS: Patients' directly elicited utilities for their own health were higher than community-derived utilities obtained from HUI and QWB administration to the same patients. HUI scores of these patients were similar to those of age-matched Canadian men. Sexual, urinary, and bowel problems were common but had less impact on overall QOL than reported in previous utility studies. These results weaken the argument that prostate cancer screening and treatment should be limited because of severe and debilitative side effects.

Overview

Integrity signals

Registry

Crossref · 10.1097/00005650-200301000-00017

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 52 references

Research works printed but not linked: 11

  1. Krahn, 1999, Can Med Assoc J, 160, 49
  2. Cantor, 1995, J Fam Pract, 41, 33
  3. Krahn, 1994, JAMA, 272, 773, 10.1001/jama.272.10.773 · doi:10.1001/jama.272.10.773 · Paper page
  4. Mold, 1992, J Fam Pract, 34, 561
  5. Litwin, 2001, J Urol, 166, 587, 10.1016/s0022-5347(05)65989-7 · doi:10.1016/s0022-5347(05)65989-7
  6. Kattan, 1997, J Gen Intern Med, 12, 299, 10.1007/s11606-006-5066-9 · doi:10.1007/s11606-006-5066-9
  7. Bennett, 1997, Eur Urol, 32, 86
  8. Shoemaker, 1982, J Economic Lit, 20, 529
  9. Kaplan, 1988, Health Serv Res, 23, 203
  10. Nease, 1995, JAMA, 273, 1185, 10.1001/jama.273.15.1185 · doi:10.1001/jama.273.15.1185 · Paper page
  11. Krahn, 1996, Med Decis Making, 16, 470

Cited by

See all 119

Metadata

Authors
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G.
Affiliations
University of Toronto (CA)
Corresponding author
  • Krahn, Murray
  • Ritvo, Paul
  • Irvine, Jane
  • Bremner, Karen E.
  • Naglie, Gary
Venue
Medical Care
Published
2003-01
Volume
41
Issue
1
Pages
153-164
ISSN
0025-7079 (ISSN-L)
OpenAlex
W2325586243
Cited by
119
References
51
Citations by year
2025: 1 · 2024: 1 · 2022: 1 · 2021: 11 · 2019: 4 · 2018: 4 · 2017: 2 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 12 · 2012: 7
FWCI
22.45
Type
journal article
Language
en
Open access
closed
Locations
  • Medical Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Urology › Prostate Cancer Diagnosis and Treatment
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Economic and Environmental Valuation
Keywords
prostate cancer, health-related quality of life, patient preferences, community preferences, sexual dysfunction, urinary dysfunction, bowel dysfunction, standard gamble, Health Utilities Index, Quality of Well-Being Scale, UCLA Prostate Cancer Index, prostate cancer screening, treatment side effects
MeSH terms
Age Factors, Aged, Aged, 80 and over, Combined Modality Therapy, Data Interpretation, Statistical, Decision Making, Health Policy, Humans, Intestinal Diseases, Male, Middle Aged, Prostatectomy, Prostatic Neoplasms, Quality of Life, Surveys and Questionnaires, Sexual Dysfunction, Physiological, Urinary Incontinence, Treatment Outcome, Patient Satisfaction, Sickness Impact Profile

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy. https://app.cochat.ai/papers/10.1097/00005650-200301000-00017
The paper
Krahn, M., Ritvo, P., Irvine, J., Tomlinson, G., Bremner, K. E., Bezjak, A., Trachtenberg, J., & Naglie, G. (2003). Patient and Community Preferences for Outcomes in Prostate Cancer: Implications for Clinical Policy. Medical Care. https://doi.org/10.1097/00005650-200301000-00017

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.